https://www.rheumatologyadvisor.com/home/topics/systemic-lupus-erythematosus/glucocorticoid-tapering-clinical-benefits-in-sle-lupus-plus-anifrolumab-tulip-trials/
0
0
9/27/22 at 4:20pm
Organization
Rheumatology Advisor
Author
Aleta Terrill
23 words
0
Comments
Researchers determined the effect of sustained glucocorticoid tapering among patients with SLE.
You are the first to view
Create an account
or login to join the discussion